- In April 2023, Sanara MedTech Inc. received FDA 510(k) clearance for Biasurge, an advanced mechanical wound cleanser designed to remove debris and microbes effectively—marking a significant innovation in surgical wound-care protocols
- In June 2025, Mölnlycke Health Care announced a EUR 115 million investment to expand its wound-care production capacity in Brunswick, Maine (USA). This expansion includes a state-of-the-art manufacturing facility aimed at increasing supply responsiveness and sustainability for North American markets
- In July 2024, Mölnlycke Health Care announced the acquisition of a leading wound cleansing manufacturer to strengthen its position as a global leader in advanced wound care. This strategic acquisition aims to consolidate Mölnlycke’s wound cleanser portfolio, expand its customer base, and accelerate innovation in infection prevention and wound healing solutions
- In June 2023, Evonik’s subsidiary JeNaCell launched Epicite Balance, a next-generation wound dressing made from biosynthetic cellulose, designed to support moist wound healing and improve patient outcomes. The product offers excellent conformability, fluid management, and compatibility with antimicrobial agents, enhancing treatment for chronic and acute wounds
